Amyris Inc
(MEX:AMRS)
MXN
1
0 (0%)
Market Cap: 12.58 Mil
Enterprise Value: 17.29 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 16/100 - Q1 2023 Amyris Inc Earnings Call TranscriptMay 09, 2023MXN18.2Earnings
- Q4 2022 Amyris Inc Earnings Call TranscriptMar 15, 2023MXN22Earnings
- Amyris Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Amyris Inc Earnings Call TranscriptNov 08, 2022MXN47Earnings
- Amyris Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 10, 2022
- Q2 2022 Amyris Inc Earnings Call TranscriptAug 09, 2022MXN46 (+15.00%)Earnings
- Amyris Inc at Oppenheimer Consumer Growth and E-Commerce Conference (Virtual) TranscriptJun 14, 2022
- Amyris Inc at UBS Global Healthcare Conference TranscriptMay 25, 2022
- Amyris Inc at Cowen Future of the Consumer: Sustainable Growth for a New Ecosystem Conference TranscriptMay 24, 2022
- Amyris Inc at Morgan Stanley Sustainable Futures Conference (Virtual) TranscriptMay 23, 2022
- Q1 2022 Amyris Inc Earnings Call TranscriptMay 10, 2022MXN70.75Earnings
- Q4 2021 Amyris Inc Earnings Call TranscriptMar 01, 2022MXN92.5Earnings
- Amyris Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Amyris Inc Financing Activity Call TranscriptNov 22, 2021
- Q3 2021 Amyris Inc Earnings Call TranscriptNov 08, 2021MXN264.2 (-11.34%)Earnings
- Amyris Inc Fourth Virtual Investor Mini-Series Webinar TranscriptSep 28, 2021
- Amyris Inc at Oppenheimer Technology, Internet & Communications Conference (Virtual) TranscriptAug 10, 2021
- Q2 2021 Amyris Inc Earnings Call TranscriptAug 05, 2021MXN292Earnings
- Amyris Inc at Jefferies Consumer Conference (Virtual) TranscriptJun 23, 2021
- Amyris Inc at Morgan Stanley Sustainable Futures Conference (Virtual) TranscriptJun 09, 2021
- Amyris Inc at Morgan Stanley Global Ingredients Conference (Virtual) TranscriptMay 18, 2021
- Q1 2021 Amyris Inc Earnings Call TranscriptMay 06, 2021Earnings
- Amyris Inc Third Virtual Investor Mini-Series Webinar TranscriptApr 22, 2021
- Q4 2020 Amyris Inc Earnings Call TranscriptMar 02, 2021Earnings
- Amyris Inc Second Virtual Investor Mini-Series Webinar TranscriptFeb 09, 2021
- Amyris Inc Science and Technology, Sustainable Solutions for a Healthier Planet Conference Call TranscriptDec 15, 2020
- Q3 2020 Amyris Inc Earnings Call TranscriptNov 05, 2020Earnings
- Q2 2020 Amyris Inc Earnings Call TranscriptAug 06, 2020Earnings
- Q1 2020 Amyris Inc Earnings Call TranscriptMay 08, 2020Earnings
- Q4 2019 Amyris Inc Earnings Call TranscriptMar 12, 2020Earnings
- Q3 2019 Amyris Inc Earnings Call TranscriptNov 07, 2019Earnings
- Q2 2019 Amyris Inc Earnings Call TranscriptOct 02, 2019Earnings
- Amyris Inc to Host Business Update Conference Call TranscriptAug 05, 2019
- Amyris Inc BioDisrupt 2019 TranscriptMay 16, 2019
- Amyris Inc at ROTH Conference TranscriptMar 19, 2019
- Q4 2018 Amyris Inc Earnings Call TranscriptMar 18, 2019Earnings
Amyris Inc at UBS Global Healthcare Conference Transcript
May 25, 2022 / 03:30PM GMT
Release Date Price:
MXN55
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
I'm John Sourbeer. I cover life sciences diagnostic tools and pharma services for UBS. Posting our next fireside chat here with Amyris, and we have John Melo, President and CEO, with us today. Hi, John.
John G. Melo
Amyris, Inc. - President, CEO & Director
Hi, John. How are you?
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Doing great.
Questions & Answers
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So I guess, maybe just to kind of start off high level to kick things off here, maybe some that are new to the Amyris story. Could you just kind of run through where the company is today and how you're positioned?
John G. Melo
Amyris, Inc. - President, CEO & Director
Sure, John. Happy to do that. First of all, great to be here. Great to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)